President Trump has signed an executive order that could reshape how cannabis is regulated at the federal level. The directive aims to reclassify the drug into a less restrictive category, a move that signals meaningful regulatory evolution. This administrative action has major implications—potentially opening doors for expanded commercial activity, clearer legal frameworks, and new opportunities across the cannabis industry nationwide. The shift represents a significant turning point in how the substance is treated under federal law, with ripple effects expected throughout related markets and business sectors.